Matthew Scalo

Matthew Scalo

Investor Relations Contact at MYRIAD GENETICS, INC.

Finance
Health Technology
Consumer Services

Profile

Matthew Scalo is currently a Senior Vice President & Investor Relations at Myriad Genetics, Inc. He previously worked as a Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc., VP, Investor Relations & Corporate Development at Cutera, Inc., and Associate at Broadpoint.
Gleacher Securities.
He also worked as a Research Analyst at Canaccord Genuity, Inc. Mr. Scalo holds an MBA degree from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Matthew Scalo active positions

CompaniesPositionStart
MYRIAD GENETICS, INC. Investor Relations Contact 01/08/2022
All active positions of Matthew Scalo

Former positions of Matthew Scalo

CompaniesPositionEnd
Analyst-Equity 31/12/2010
Analyst-Equity 22/04/2010
Analyst-Equity 31/12/2003
Analyst-Equity 31/12/2002
NEXTGEN HEALTHCARE, INC. Investor Relations Contact -
See the detail of Matthew Scalo's experience

Training of Matthew Scalo

University of Notre Dame Masters Business Admin
University of California, Davis Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Scalo's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MYRIAD GENETICS, INC.

Health Technology

CUTERA, INC.

Health Technology

Private companies6

Technology Services

Finance

Health Technology

Finance

Finance

Finance

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW